Literature DB >> 30561576

Pacing parameters and success rates of permanent His-bundle pacing in patients with narrow QRS: a single-centre experience.

Lan Su1,2, Shengjie Wu1,2, Songjie Wang1,2, Zhengxian Wang1,2, Fangyi Xiao1,2, Peiren Shan1,2, Hao Zhou1,2, Zhouqing Huang1,2, Lei Xu1,2, Weijian Huang1,2.   

Abstract

AIMS: High and unstable capture thresholds affect the success rate of permanent His-bundle pacing (HBP). We aimed to introduce the modified techniques during different periods and the corresponding success rate of HBP implantation. METHODS AND
RESULTS: Patients from a single centre who had intrinsic QRS < 120 ms and HBP attempts were included in the study. The success rate and pacing parameters were described for three periods based on procedural modifications, i.e. Stage 1 using the conventional HBP procedure (August 2012 to May 2013), Stage 2 with addition of the dual-lead method (June 2013 to October 2014), and Stage 3 with the further addition of stability assessment during fixation (November 2014 to October 2016). The patients with successful permanent HBP were followed. A total of 310 patients were included with the average age of 70.3 ± 10.7 years. The success rate of acute HBP was 84.85%, 98.3%, and 99.20% during Stages 1-3, respectively (P < 0.001). The permanent HBP implantation rates increased from 77.3% during Stage 1 to 85.7% during Stage 2 and 89.6% during Stage 3 (P = 0.07). The acute His-bundle capture threshold reduced from 1.30 ± 0.7 V/0.5 ms during Stage 1 to 1.11 ± 0.6 V/0.5 ms during Stage 2 and further to 0.85 ± 0.51 V/0.5 ms during Stage 3 (P < 0.001). At the 12-month follow-up, the mean change in the HBP threshold decreased from 0.60 ± 0.59 V/0.5 ms during Stage 1 to 0.33 ± 0.39 V/0.5 ms during Stage 3 (P = 0.002).
CONCLUSION: The HBP implantation success rate, pacing threshold, and its stability during follow-up were improved by using the dual-lead method and stability assessment techniques. Published on behalf of the European Society of Cardiology. All rights reserved.
© The Author(s) 2018. For permissions, please email: journals.permissions@oup.com.

Entities:  

Keywords:  His-bundle pacing; Pacemaker; Pacemaker implantation; Pacing lead; Success rate; Threshold

Year:  2019        PMID: 30561576     DOI: 10.1093/europace/euy281

Source DB:  PubMed          Journal:  Europace        ISSN: 1099-5129            Impact factor:   5.214


  6 in total

Review 1.  Safety and efficacy of His-bundle pacing/left bundle branch area pacing versus right ventricular pacing: a systematic review and meta-analysis.

Authors:  Xinyi Peng; Yu Chen; Xiaofei Wang; Aizhen Hu; Xuexun Li
Journal:  J Interv Card Electrophysiol       Date:  2021-05-21       Impact factor: 1.900

2.  Impact of QRS morphology on response to conduction system pacing after atrioventricular junction ablation.

Authors:  Shengjie Wu; Mengxing Cai; Rujie Zheng; Songjie Wang; Limeng Jiang; Lei Xu; Ruiyu Shi; Fangyi Xiao; Kenneth A Ellenbogen; Yongmei Cha; Lan Su; Weijian Huang
Journal:  ESC Heart Fail       Date:  2021-01-04

3.  Deep septal, distal His bundle pacing to achieve low and stable capture threshold.

Authors:  Yoji Iida; Tomoaki Izawa; Chikara Kobari; Toru Yatsuhashi; Nobuyuki Makishima
Journal:  HeartRhythm Case Rep       Date:  2020-10-16

4.  Conduction System Pacing for Post Transcatheter Aortic Valve Replacement Patients: Comparison With Right Ventricular Pacing.

Authors:  Hong-Xia Niu; Xi Liu; Min Gu; Xuhua Chen; Chi Cai; Minsi Cai; Shu Zhang; Wei Hua
Journal:  Front Cardiovasc Med       Date:  2021-11-30

5.  Permanent left bundle branch area pacing utilizing intracardiac echocardiogram.

Authors:  Xiang-Fei Feng; Peng-Pai Zhang; Bo Liu; Yan Zhao; Qiu-Fen Lu; Yi-Gang Li
Journal:  BMC Cardiovasc Disord       Date:  2020-08-18       Impact factor: 2.298

6.  Assessment of ventricular mechanical synchronization after left bundle branch pacing using 2-D speckle tracking echocardiography.

Authors:  Zhijun Sun; Beibing Di; Huikuan Gao; Dihui Lan; Hui Peng
Journal:  Clin Cardiol       Date:  2020-10-21       Impact factor: 2.882

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.